Coordinating a program of “Southern Stories” dedicated to the 20th anniversary of Hurricane Katrina was more than an ...

The stock market opened cautiously as discussions on the Israel-Hamas peace agreement coincided with Trump's Gaza Peace Plan.

Sales of Biogen’s BIIB key multiple sclerosis (“MS”) drugs like Tecfidera and Tysabri and spinal muscular atrophy (SMA) ...

SMA Europe has launched an online tool designed to help patients, doctors, and others in the spinal muscular atrophy (SMA) ...

Affordable Risdiplam is now within reach for Spinal Muscular Atrophy (SMA) patients in India, thanks to a Delhi High Court ...

The HC rejected his plea, holding that once a person solemnises marriage under the Special Marriage Act (SMA), the ...

The Delhi High Court has dismissed Roche's appeal, allowing Natco to launch a generic version of Risdiplam for spinal ...

Novartis is seeking to repurpose its investigational oral spinal muscular atrophy (SMA) drug branaplam to treat Huntington's disease, the Swiss drugmaker said on Wednesday, as it plans a clinical ...

Swiss drugmaker Roche on Monday said 59% of infants with the severest form of spinal muscular atrophy could sit for at least five seconds after getting its drug Evrysdi for two years, according to ...

Target trades at historically low multiples, with downside risks likely priced in, and offers a compelling 5.12% dividend.

The exergame Tales from the Magic Keep aims to boost physical activity, and proved to be a feasible tool for children with ...

Shares of Ouster, Inc. OUST closed at $32.69, above its 50-day moving average of $28.93, indicating a bullish trend. Shares ...